WebApr 12, 2024 · Keywords: DNA methylation, adenosine, receptor-independent pathway, adenosine kinase, ADK isoforms, ADK inhibitor, cancer therapy Citation: Luo H-Y, Shen H-Y, Perkins RS and Wang Y-X (2024) Corrigendum: Adenosine kinase on deoxyribonucleic acid methylation: Adenosine receptor-independent pathway in cancer therapy. Front. … Web2 days ago · By Berkeley Lovelace Jr., John Torres, M.D., Marina Kopf and Patrick Martin Researchers in Boston are on the verge of what they say is a major advancement in lung …
Frontiers Treatment options for recurrent platinum-resistant …
WebApr 6, 2024 · Breast cancer (BC) is the most prevalent malignant tumor, surpassing lung cancer as the most frequent malignancy in women. Drug resistance, metastasis, and immune escape are the major factors affecting patient survival and represent a huge challenge in BC treatment in clinic. The cell- and subcellular organelle-targeting … WebApr 11, 2024 · BackgroundThere are a variety of treatment options for recurrent platinum-resistant ovarian cancer, and the optimal specific treatment still remains to be determined. Therefore, this Bayesian network meta-analysis was conducted to investigate the optimal treatment options for recurrent platinum-resistant ovarian cancer.MethodsPubmed, … how do people catch cholera
Frontiers Media - Wikipedia
WebOct 27, 2024 · From November 1-3, 2024, Singapore will hold its 13 th Frontiers in Cancer Science (FCS) conference virtually. This annual conference started in 2009 as a one-day symposium for the common purpose of sharing and advancing knowledge both locally and with the global scientific community. WebJun 7, 2024 · Frontiers in Oncology, a recurring seminar series organized by the Stanford Cancer Institute, is designed to highlight innovations in cancer research across the spectrum of basic, translational, clinical and population science. WebApr 12, 2024 · 1 Introduction. Breast cancer is the most common malignant tumor in women globally and has four histological subtypes: triple-negative, human epidermal growth factor receptor 2 (HER2)-overexpress, luminal A, and luminal B (2–4).Significant prognostic differences exist among these four subtypes (5, 6).The prognosis for luminal breast … how do people catch hepatitis c